Huaqiang XU

Person

Quzhou, CN

People

Patents Grantslast 30 patents

Information Patent Grant
Liver-specific delivery-based anti-hepatitis C prodrug nucleoside c...
- Patent number 11,008,361
- Issue date May 18, 2021
- ZHEJIANG PALO ALTO PHARMACEUTICALS, INC
- Zhijian Xi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Liver specific delivery-based gemcitabine prodrug nucleoside cyclic...
- Patent number 10,913,765
- Issue date Feb 9, 2021
- Zhijian Xi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Liver specific delivery-based entecavir prodrug, nucleoside cyclic...
- Patent number 10,913,766
- Issue date Feb 9, 2021
- Zhijian Xi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Cytarabine prodrug nucleoside cyclic phosphate compound based on li...
- Patent number 10,899,787
- Issue date Jan 26, 2021
- Zhijian Xi
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Liver specific delivery-based antiviral prodrug nucleoside cyclopho...
- Patent number 10,668,090
- Issue date Jun 2, 2020
- ZHEJIANG PALO ALTO PHARMACEUTICALS, INC
- Zhijian Xi
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Hepatitis C virus inhibitor and uses thereof
- Patent number 10,640,515
- Issue date May 5, 2020
- ZHEJIANG PALO ALTO PHARMACEUTICALS, INC
- Zhijian Xi
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
CYTARABINE PRODRUG NUCLEOSIDE CYCLIC PHOSPHATE COMPOUND BASED ON LI...
- Publication number 20200317711
- Publication date Oct 8, 2020
- ZHEJIANG PALO ALTO PHARMACEUTICALS, INC.
- Zhijian XI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
LIVER SPECIFIC DELIVERY-BASED GEMCITABINE PRODRUG NUCLEOSIDE CYCLIC...
- Publication number 20200317712
- Publication date Oct 8, 2020
- ZHEJIANG PALO ALTO PHARMACEUTICALS, INC.
- Zhijian XI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIVER SPECIFIC DELIVERY-BASED ENTECAVIR PRODRUG, NUCLEOSIDE CYCLIC...
- Publication number 20200317713
- Publication date Oct 8, 2020
- ZHEJIANG PALO ALTO PHARMACEUTICALS, INC.
- Zhijian XI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIVER-SPECIFIC DELIVERY-BASED ANTI-HEPATITIS C PRODRUG NUCLEOSIDE C...
- Publication number 20200048299
- Publication date Feb 13, 2020
- ZHEJIANG PALO ALTO PHARMACEUTICALS,INC
- Zhijian XI
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HEPATITIS C VIRUS INHIBITOR AND USES THEREOF
- Publication number 20190135828
- Publication date May 9, 2019
- ZHEJIANG PALO ALTO PHARMACEUTICALS,INC
- Zhijian XI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIVER SPECIFIC DELIVERY-BASED ANTIVIRAL PRODRUG NUCLEOSIDE CYCLOPHO...
- Publication number 20190125771
- Publication date May 2, 2019
- ZHEJIANG PALO ALTO PHARMACEUTICALS,INC
- Zhijian XI
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Huaqiang XU

Person

Patents Grantslast 30 patents

Liver-specific delivery-based anti-hepatitis C prodrug nucleoside c...

Liver specific delivery-based gemcitabine prodrug nucleoside cyclic...

Liver specific delivery-based entecavir prodrug, nucleoside cyclic...

Cytarabine prodrug nucleoside cyclic phosphate compound based on li...

Liver specific delivery-based antiviral prodrug nucleoside cyclopho...

Hepatitis C virus inhibitor and uses thereof

Patents Applicationslast 30 patents

CYTARABINE PRODRUG NUCLEOSIDE CYCLIC PHOSPHATE COMPOUND BASED ON LI...

LIVER SPECIFIC DELIVERY-BASED GEMCITABINE PRODRUG NUCLEOSIDE CYCLIC...

LIVER SPECIFIC DELIVERY-BASED ENTECAVIR PRODRUG, NUCLEOSIDE CYCLIC...

LIVER-SPECIFIC DELIVERY-BASED ANTI-HEPATITIS C PRODRUG NUCLEOSIDE C...

HEPATITIS C VIRUS INHIBITOR AND USES THEREOF

LIVER SPECIFIC DELIVERY-BASED ANTIVIRAL PRODRUG NUCLEOSIDE CYCLOPHO...